Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Archambault

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Medicine|January 1, 1979
Butorphanol/acetaminophen double-blind study in postoperative painR E Young, J J Quigley, W A Archambault, et al.
Chronic Diseases in Canada|August 24, 1999
Rate and cost of hospitalizations for asthma in Quebec: An analysis of 1988/89, 1989/90 and 1994/95 dataC Laurier, W Kennedy, J L Malo, et al.
Bone Marrow Transplantation|August 12, 2009
Munchausen's syndrome in the allogeneic stem cell transplantation setting: a rare but potentially devastating conditionM-A Archambault-Grenier, J Roy, N Beauchemin, et al.
The American Journal of Gastroenterology|September 1, 1985
A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcerA Farley, D Lévesque, P Paré, et al.
L'Union Medicale Du Canada|June 1, 1977
[Effects on the gastric mucosa of coated acetylsalicylic acid (Entrophen) and ordinary acetylsalicylic acid: comparative study by endoscopy]Y Giroux, A Archambault, A Farley, et al.
L'Union Medicale Du Canada|October 1, 1971
[Carcinoid syndrome. Presentation of a clinical case]A Archambault, D Palaic, P Perras, et al.
Immunity|March 10, 2001
STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiationM L McLemore, S Grewal, F Liu, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 15, 2007
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trialS B Hanauer, W J Sandborn, C Dallaire, et al.
Applied Biochemistry and Biotechnology|April 1, 2004
Extraction of antioxidant compounds from energy cropsChing S Lau, Danielle Julie Carrier, Luke R Howard, et al.
Journal of Strength and Conditioning Research|August 13, 2005
Comparison of muscle activation using various hand positions during the push-up exerciseRobert M Cogley, Teasha A Archambault, Jon F Fibeger, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Medicine|January 1, 1979
Butorphanol/acetaminophen double-blind study in postoperative painR E Young, J J Quigley, W A Archambault, et al.
Chronic Diseases in Canada|August 24, 1999
Rate and cost of hospitalizations for asthma in Quebec: An analysis of 1988/89, 1989/90 and 1994/95 dataC Laurier, W Kennedy, J L Malo, et al.
Bone Marrow Transplantation|August 12, 2009
Munchausen's syndrome in the allogeneic stem cell transplantation setting: a rare but potentially devastating conditionM-A Archambault-Grenier, J Roy, N Beauchemin, et al.
The American Journal of Gastroenterology|September 1, 1985
A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcerA Farley, D Lévesque, P Paré, et al.
L'Union Medicale Du Canada|June 1, 1977
[Effects on the gastric mucosa of coated acetylsalicylic acid (Entrophen) and ordinary acetylsalicylic acid: comparative study by endoscopy]Y Giroux, A Archambault, A Farley, et al.
L'Union Medicale Du Canada|October 1, 1971
[Carcinoid syndrome. Presentation of a clinical case]A Archambault, D Palaic, P Perras, et al.
Immunity|March 10, 2001
STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiationM L McLemore, S Grewal, F Liu, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 15, 2007
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trialS B Hanauer, W J Sandborn, C Dallaire, et al.
Applied Biochemistry and Biotechnology|April 1, 2004
Extraction of antioxidant compounds from energy cropsChing S Lau, Danielle Julie Carrier, Luke R Howard, et al.
Journal of Strength and Conditioning Research|August 13, 2005
Comparison of muscle activation using various hand positions during the push-up exerciseRobert M Cogley, Teasha A Archambault, Jon F Fibeger, et al.
Pageof 6